Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma

Black, Jonathan D.

401
Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

J. D. Black¹, S. Lopez², S. Bellone¹, C. L. Schwab¹, D. P. English¹, D. M. Roque³, D. A. Silasi¹, E. S. Ratner¹, M. Azodi¹, T. J. Rutherford¹, P. E. Schwartz¹ and A. Santin¹
¹Yale University School of Medicine, New Haven, CT, ²University Campus Bio-Medico of Rome, Rome, Italy, ³University of Maryland School of Medicine, Baltimore, MD

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

401
Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma

401 Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma

401
Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma